A novel CYR61/ER connection is regulates anti-estrogen resistance in breast cancer.

被引:0
|
作者
Espinoza, I
Rasor, G.
Liu, H.
Lupu, R.
机构
[1] Evanston NW Healthcare Res Inst, Evanston, IL USA
[2] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S159 / S159
页数:1
相关论文
共 50 条
  • [21] Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer
    Hirschfeld, Marc
    zur Hausen, Axel
    Bettendorf, Herta
    Jaeger, Markus
    Stickeler, Elmar
    CANCER RESEARCH, 2009, 69 (05) : 2082 - 2090
  • [22] Cyr61 as mediator of Src signaling in triple negative breast cancer cells
    Sanchez-Bailon, Maria Pilar
    Calcabrini, Annarica
    Mayoral-Varo, Victor
    Molinari, Agnese
    Wagner, Kay-Uwe
    Perez Losada, Jesus
    Ciordia, Sergio
    Pablo Albar, Juan
    Martin-Perez, Jorge
    ONCOTARGET, 2015, 6 (15) : 13520 - 13538
  • [23] ESTROGEN AND ANTI-ESTROGEN EFFECTS IN BREAST-CANCER EXPLANTS
    COOKE, T
    GEORGE, D
    GRIFFITHS, K
    SHIELDS, R
    BRITISH JOURNAL OF SURGERY, 1980, 67 (05) : 375 - 375
  • [24] Combined Antiangiogenic and Anti-Estrogen Therapy in Breast Cancer. Molecular Mechanisms Involved.
    de la Haba, J.
    Berciano, M.
    Canabate, M.
    Porras, I.
    Valverde, A.
    Canas, A.
    Rodriguez, A.
    Aranda, E.
    CANCER RESEARCH, 2011, 71
  • [25] Sox4 Up-Regulates Cyr61 Expression in Colon Cancer Cells
    Wu, Gang
    Zhu, Yuan-Zeng
    Zhang, Jian-Cheng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (02) : 405 - 412
  • [26] Novel dual modulator of estrogen sulfatase and estrogen receptor (ER) for the treatment of ER plus breast cancer.
    Chao, WR
    Peters, RH
    Zaveri, N
    Tanabe, M
    Yamada, Y
    Toko, T
    Asao, T
    Eshima, K
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S103 - S103
  • [27] When Breast Cancer Wants to Spread, Suppress CYR61/CCN1
    Hellinger, Johanna
    Silke, Huechel
    Goetz, Lena
    Bauerschmitz, Gerd
    Emons, Guenter
    Gruendker, Carsten
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 13 - 13
  • [28] Functional domains of CCN1 (Cyr61) regulate breast cancer progression
    O'Kelly, James
    Chung, Alice
    Lemp, Nathan
    Chumakova, Katya
    Yin, Dong
    Wang, He-Jing
    Said, Jonathan
    Gui, Dorina
    Miller, Carl W.
    Karlan, Beth Y.
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (01) : 59 - 67
  • [29] Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer
    Mayer, Sebastian
    Erbes, Thalia
    Timme-Bronsert, Sylvia
    Jaeger, Markus
    Ruecker, Gerta
    Kuf, Franciska
    Stickeler, Elmar
    Gitsch, Gerald
    Hirschfeld, Marc
    ONCOLOGY LETTERS, 2017, 14 (02) : 2334 - 2340
  • [30] ANTI-ESTROGEN TREATMENT OF BREAST-CANCER - AN OVERVIEW
    PEARSON, OH
    MANNI, A
    ARAFAH, BM
    CANCER RESEARCH, 1982, 42 (08) : 3424 - 3429